Evolving ADC Discovery to Design & Develop Next-Generation ADCs with Differentiated Therapeutic Profiles
- Leveraging automation to improve efficiency and throughput for ADC discovery
- Laying out the GSK approach and attitude to ADC discovery to ensure development of future ADC therapeutic impact
- Highlighting novel linker-payload design approaches to improve ADC physicochemical properties and tumour targeting specificity